Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
모아데이타 was founded in March 2014 as Korea’s first company to launch an artificial intelligence-based anomaly detection and prediction solution. Its flagship product "페타온 포캐스터" leads the domestic AIOps market for ICT system infrastructure. The company has expanded into digital healthcare by applying its core AI technologies to services that detect anomalies in human health data. It also develops manufacturing execution system solutions for smart factories, focusing on predictive maintenance using AI. In addition, 모아데이타 holds exclusive domestic distribution rights for SolarWinds network management products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 모아데이타.